Dexmedetomidine for Prophylaxis Against PONV in Highly Susceptible Patients.

• Status: Active, not recruiting
• Trial end date: 2022-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The study aims to compare between two bolus doses of dexmedetomidine in preventing PONV in highly susceptible patients.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Cairo University
• Treatments: Dexmedetomidine

Criteria

Inclusion Criteria:

• More than 2 risk factors for PONV ( female, non-smoking, postoperative opioids, history of motion sickness or PONV )

• Head and neck surgeries in adults

• ASA ( I , II )

Exclusion Criteria:

• Patients on ( steroids , antiemetics or any drug caude emesis )

• Any active cardiac condition at the time of the surgery

• Pregnancy